381 filings
DEF 14A
OMER
Omeros Corporation
Definitive proxy
29 Apr 24
5:23pm
ARS
2023 FY
OMER
Omeros Corporation
29 Apr 24
Annual report to shareholders
5:22pm
10-K
2023 FY
OMER
Omeros Corporation
Annual report
1 Apr 24
5:20pm
8-K
OMER
Omeros Corporation
1 Apr 24
Omeros Corporation Reports Fourth Quarter and Year-End 2023 Financial Results
4:06pm
8-K
OMER
Omeros Corporation
7 Feb 24
Entry into a Material Definitive Agreement
8:00am
8-K
3zz1nreeocxn23bc
9 Nov 23
Omeros Corporation Reports Third Quarter 2023 Financial Results
4:05pm
8-K
9zld zyavc0
16 Oct 23
Omeros Corporation Provides Update on Interim Analysis of ARTEMIS-IGAN Phase 3 Trial of Narsoplimab in IgA Nephropathy
4:36pm
S-8
4h9o0
9 Aug 23
Registration of securities for employees
5:20pm
8-K
4ay2k252y 4rcw86ht
9 Aug 23
Omeros Corporation Reports Second Quarter 2023 Financial Results
8:00am
8-K
9aagup
28 Jun 23
Departure of Directors or Certain Officers
5:25pm
ARS
9fyd98v7k4 wc5bd56
17 May 23
Annual report to shareholders
5:06pm
8-K
k5mtq 3pstt
16 May 23
Departure of Directors or Certain Officers
5:10pm
8-K
1mka1d5
9 May 23
Omeros Corporation Reports First Quarter 2023 Financial Results
4:05pm
8-K
llaov6w3ovnf0n2 3z
13 Mar 23
Omeros Corporation Reports Fourth Quarter and Year-End 2022 Financial Results
4:05pm